Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AUTOMATIC EXTERNAL DEFIBRILLATOR AVAILABILITY TO GENERAL PUBLIC

This article was originally published in The Gray Sheet

Executive Summary

AUTOMATIC EXTERNAL DEFIBRILLATOR AVAILABILITY TO GENERAL PUBLIC would raise unique pre- and postmarket issues of safety and effectiveness, Susan Alpert, director of FDA's Office of Device Evaluation, said Dec. 8 at an American Heart Association conference in Washington, D.C. The conference, entitled "Public Access Defibrillation: A New Strategy to Prevent Sudden Death," was held to explore the feasibility of making the devices available in such public gathering places as office buildings, stadiums, or homes, to enable faster treatment of patients needing defibrillation.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel